Advisors Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$702K	Buy	138,822 +5,337	+4%	+$27K	0.01%	876
2025 Q1	$706K	Buy	133,485 +117,851	+754%	+$623K	0.01%	854
2024 Q4	$106K	Buy	+15,634	New	+$106K	﹤0.01%	1218